Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Heng Liu
AddedFeb 13, 2024
UpdatedJul 2, 2026
Heng Liu

Heng Liu

Co-Founder & CEO, Chairman, LongBio Pharma

Heng Liu's Career

LongBio Pharma
LongBio Pharma

Changshu, Jiangsu, CN

Co-Founder & CEO, Chairman
Bridgelux
Bridgelux

Sunnyvale, CA, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Heng Liu's Career

LongBio Pharma
LongBio Pharma
Series C$300M2020Changshu, Jiangsu, CN
Co-Founder & CEO, Chairman

Recent news

Chinese biotech startup LongBio Pharma lists on Hong Kong stock exchangeBioSpectrum Asia · 2026
China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock ExchangePR Newswire · 2026
Longbio to raise HK$1.4B in Hong Kong IPO for immunology workBioWorld · 2026

Leadership at LongBio Pharma

Naichao SunNaichao SunCo-founder

Similar to LongBio Pharma

Long Bridge MedicalLong Bridge MedicalSouth San Francisco, CA, USBiotech, Softwareest. 2018Long Bridge MedicalSouth San Francisco, CA, US · est. 2018

Innovative software & biotech company in South San Francisco.

Seed · $3.6M5
Arranta BioArranta BioWatertown, MA, USBiotherapeutics, Manufacturingest. 2019Arranta BioWatertown, MA, US · est. 2019

Arranta Bio: Contract development and manufacturing of live biotherapeutic products.

Series B · $82M102
BioRay PharmaceuticalsBioRay PharmaceuticalsShanghai, Shanghai, CNMedicines, Pharmaceuticalsest. 2019BioRay PharmaceuticalsShanghai, Shanghai, CN · est. 2019

Leading biopharmaceutical company in China, specializing in immune-mediated diseases and cancer treatments. Visit www.bioraypharm.com.

Public · $2.5B3k
Bridgelux
Bridgelux
Late Stage Private$344.8M752002Sunnyvale, CA, US
Founder

Leadership at Bridgelux

George de UriosteGeorge de UriosteBoard Member
Yi-Qun LiYi-Qun LiCEO
Nelson ChanNelson ChanBoard Member
Alan SalzmanAlan SalzmanBoard Member

Similar to Bridgelux

Exact LuxExact LuxBoston, MA, USLED Lightingest. 2016Exact LuxBoston, MA, US · est. 2016

Exact Lux: Innovators in LED lighting systems with technology to combat light depreciation.

Angel · $65k5
Luxul TechnologyLuxul TechnologySanta Clara, CA, USLED Lamps, Lightingest. 2010Luxul TechnologySanta Clara, CA, US · est. 2010

Californian LED lamp provider, Luxul Technology, offers energy-saving, easy-installation lighting solutions backed by 50+ global patents.

Series A · $6.8M75
LuxtechLuxtechPhiladelphia, PA, USLED Modules, Lightingest. 2012LuxtechPhiladelphia, PA, US · est. 2012

LUXTECH: A leading innovator and manufacturer of specification-grade LED modules for architectural lighting.

Pre-Seed · $1M32
LuxeraLuxeraFremont, CA, USLED Driversest. 2010LuxeraFremont, CA, US · est. 2010

Luxera: A fabless semiconductor company innovating LED driver solutions for retrofit lighting.

Series A · $4M30

Heng Liu's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · Kakao

People Similar to Heng Liu

Anindya RoyAnindya RoyCo-Founder · AlltiusRick LeungRick LeungCo-Founder · VyoptaSiheng HuangSiheng HuangCo-Founder · GtriipXiaoming ZhangXiaoming ZhangCo-Founder · Theron PharmaceuticalsSunil KosuriSunil KosuriFounder · RightHireKetal PatelKetal PatelCo-Founder · Vitalxchange